Effectively, this strategy would attenuate both geographic atrophy and exudative AMD and promote photoreceptor survival by reducing proinflammatory mediators such as VEGF, attenuate pathologic phagocytosis, promote homeostatic phagocytosis, and secrete neuroprotective growth factors [55,129,142]. Here, VEGFA is linked to atrophic macular degeneration.